Drug Shortage Report for SUCCINYLCHOLINE CHLORIDE INJECTION USP

Last updated on 2021-03-13 History
Report ID 85107
Drug Identification Number 02422336
Brand name SUCCINYLCHOLINE CHLORIDE INJECTION
Common or Proper name Succinylcholine Chloride
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SUCCINYLCHOLINE CHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML
ATC code M03AB
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-05-28
Actual start date 2019-05-28
Estimated end date 2021-03-12
Actual end date 2021-03-12
Shortage status Resolved
Updated date 2021-03-13
Company comments Product is now available at wholesalers for Hospital use only. Allocation is set at 100%-200% of historical demands based on region.
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v42 2021-03-13 French Compare
v41 2021-03-12 French Compare
v40 2021-03-12 English Compare
v39 2021-02-26 French Compare
v38 2021-02-26 English Compare
v37 2021-01-29 French Compare
v36 2021-01-29 English Compare
v35 2020-06-22 French Compare
v34 2020-06-22 English Compare
v33 2020-06-03 French Compare
v32 2020-06-03 English Compare
v31 2020-05-29 French Compare
v30 2020-05-29 English Compare
v29 2020-04-30 French Compare
v28 2020-04-30 English Compare
v27 2020-04-09 French Compare
v26 2020-04-09 English Compare
v25 2020-02-27 French Compare
v24 2020-02-27 English Compare
v23 2020-01-28 French Compare

Showing 1 to 20 of 42